The age-specific penetrance for CM in CDKN2A mutation carriers is high in Denmark, as in other high incidence melanoma countries [51], and MC1R variants modulate the penetrance of CM and the risk of MPM. This evidence concerns the gene CDKN2A and cutaneous mastocytosis.